Cipla and 3 other fundamentally strong stocks with low debt and PE less than the industry

Synopsis:: Four fundamentally strong stocks with low debt-to-equity ratios below 0.02 and valuations trading at PE lower than their industry averages emerged as attractive picks. One of them also holds a 16.6% market share in its sector. Together, they combine stable balance sheets with compelling long-term value.

In today’s market landscape, investors continue to favour companies that demonstrate both financial discipline and consistent operational performance. This list brings together four such fundamentally solid businesses across diverse sectors like insurance, cement, pharmaceuticals, and media. 

Despite operating in different industries, they share common strengths: clean balance sheets with low leverage, price-to-earnings ratios that sit comfortably below sector averages, and proven market presence backed by steady growth. These characteristics not only enhance their resilience in uncertain conditions but also make them compelling candidates for long-term wealth creation.

LIC

The Life Insurance Corporation of India (LIC) is widely regarded as the largest life insurance provider in India, commanding the biggest share of new business premiums. The company offers a broad suite of insurance products, including participating plans, unit-linked policies (ULIPs), savings and term insurance products, health plans, and annuity/pension solutions, which cover a wide spectrum of customer needs.

With the market cap of Rs 5,49,009, the shares of Life Insurance Corporation of India have closed at Rs 868 on Friday; the shares have given a return of 5% since their listing in May 2022 and have an ROCE and ROE of 53.1% and 45.7%, respectively. 

The company demonstrates strong financial discipline, reflected in its low debt-to-equity ratio of 0, which highlights its prudent use of leverage and ability to fund operations without relying heavily on borrowing. This conservative capital structure contributes to long-term stability and reduces financial risk. Additionally, the stock appears attractively valued, trading at a PE of 10.8, notably lower than the industry average PE of 85.2. Such a valuation gap suggests the company may be undervalued relative to its peers despite its healthy fundamentals. Together, the low debt burden and favorable valuation strengthen the company’s investment appeal and position it well for sustainable growth.

Ambuja Cement.  

Ambuja Cements is part of Adani Cement, the cement vertical of the Adani Group, which also includes ACC and has expanded through acquisitions such as Sanghi and Penna. The Adani Group itself has a diversified presence across energy, utilities, transport, logistics, materials and mining. With rapid consolidation in the cement space, Adani Cement has emerged as one of India’s largest producers, and Ambuja’s market share stood at 16.6% in Q2 FY26, reflecting its strong position within the sector.

With the market cap of Rs 1,35,468, the shares of Ambuja Cements Ltd have closed at Rs 548 on Friday; the shares have given a return of 122% over the last 5 years and have an ROCE and ROE of 10.5% and 8.73%, respectively. 

The company’s financials look comfortable, with a low debt-to-equity ratio of 0.02, showing that it hasn’t depended much on borrowing and has kept its balance sheet clean. This gives it the flexibility to handle tough phases and still invest in growth when needed. On the valuation side, the stock trades at a PE of 23.6, which is lower than the industry average of 32.6. This suggests the market may not be fully pricing in the company’s strengths yet. Together, its low debt levels and relatively cheaper valuation make it look like a solid and reasonably priced business in its sector.

Cipla ltd 

Cipla, founded in 1935, is one of India’s most established pharmaceutical companies, built on a mission to make healthcare accessible and affordable. With a strong presence across India, South Africa and North America, the company offers a wide portfolio of medicines spanning respiratory, anti-retroviral, urology, cardiology and other key therapeutic areas. Known for its values-driven approach and longstanding focus on patient needs, Cipla has grown into a major global player and remains one of India’s leading pharma manufacturers with significant market strength in several international regions, including South Africa.

With the market cap of Rs 1,22,389, the shares of Cipla Ltd have closed at Rs 1,515 on Friday; the shares have given a return of 100% over the last 5 years and have an ROCE and ROE of 22.7% and 17.8%, respectively. 

The company stands out for its clean balance sheet, reflected in a debt-to-equity ratio of just 0.01, which shows it has kept borrowing well under control. This low dependence on debt gives it stability and room to grow without financial strain. What also works in its favour is its valuation; the stock trades at a PE of 22.5, noticeably lower than the industry average of 31. This gap suggests the company could be priced more conservatively than its peers, even though its fundamentals remain strong. Overall, the mix of low leverage and a reasonable valuation makes it an appealing, financially sound pick.

Sun TV Network Ltd. 

Sun TV Network began in 1985 as Sumangali Publications Private Limited and was later renamed to Sun TV Network Limited. Its flagship TV channel, Sun TV, was launched in 1993, and the group is chiefly engaged in television broadcasting. In addition to its TV operations, the company also produces and distributes films under its movie‐making arm, Sun Pictures.

With the market cap of Rs 22,181, the shares of Sun TV Network Ltd have closed at Rs 563 on Friday; the shares have given a return of 20% over the last 5 years and have an ROCE and ROE of 20.4% and 15.7%, respectively. 

The company’s balance sheet is on solid ground, supported by a debt-to-equity ratio of 0.01, which shows that it has kept its borrowings in check and operates with financial caution. This low debt load not only reduces risk but also leaves room for future expansion without pressure.

At the same time, its stock looks attractively priced, with a PE of 13.4 compared to the industry’s 19.8, hinting that the market may be valuing it more modestly than its peers. Taken together, its light debt profile and favorable valuation make the company stand out as a stable and potentially undervalued option. 

Written by Leon Mendonca. 

Disclaimer

The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Cipla and 3 other fundamentally strong stocks with low debt and PE less than the industry appeared first on Trade Brains.